Coy Heldermon

Coy Heldermon, M.D., Ph.D.

ASO PROF

Department: MD-HEMATOLOGY/ONCOLOGY
Business Phone: (352) 273-8008

About Coy Heldermon

Dr. Heldermon is an associate professor of medicine, board certified medical oncologist with expertise in the treatment of breast cancer. He is a member of the American Society of Hematology and the American Society of Clinical Oncology. His research expertise is in the use of gene replacement and stem cell therapies for the treatment of inherited disorders such as lysosomal storage diseases. He also studies the spread of stem cells from maternal or malignant sources using mouse models.

Board Certifications

  • Internal Medicine
    American Board of Internal Medicine
  • Oncology
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Medicine
Subspecialties
  • Oncology
Areas of Interest
  • Breast cancer
  • Cancer – resources
  • Gaucher disease
  • Mucopolysaccharidosis type III
  • Stem cell research

Publications

2013 Molecular Genetics and Metabolism

Grants

Jul 2019 ACTIVE
Novel oral targeted breast carcinoma vaccine
FL BREAST CANCER FOU · Project Manager
Jul 2018 ACTIVE
A new approach for eradicating metastatic, drug-resistant breast cancers
OCALA ROYAL DAMES FOR CANCER RESEARCH ·
Feb 2018 – Jan 2019
Novel isoform-selective HDAC inhibitor for enhancing cancer immunotherapy against breast cancer
FL BREAST CANCER FOU ·
Sep 2017 ACTIVE
UFHCC Triple Negative Breast Cancer (TNBC) Pilot Project Program
MULTIPLE SPONSORS · Project Manager
Aug 2017 ACTIVE
Optimizing AAV Vectors for Central Nervous System transduction
NATL INST OF HLTH NINDS · Principal Investigator
May 2017 – Jun 2018
Gene therapy with intracranial delivery of capsid enhanced AAV NAGLU
FUNDACJA SANFILIPPO · Principal Investigator
Mar 2017 ACTIVE
Neural and mesenchymal stem cell mediated gene therapy for Sanfilippo Syndrome B
THE SANFILIPPO CHILDRENS RES FOU · Principal Investigator
Mar 2017 – Mar 2019
Neural and mesenchymal stem cell mediated gene therapy for Sanfilippo Syndrome B
CURE SANFILIPPO FOU · Principal Investigator
May 2016 – Jun 2019
Gene therapy with intracranial delivery of capsid enhanced AAV NAGLU
SAN FILIPPO CHILDRENS FOU · Principal Investigator
May 2016 – Jun 2018
Gene therapy with intracranial delivery of capsid enhanced AAV NAGLU
SANFILIPPO INITIATIVE E V · Principal Investigator
Mar 2016 ACTIVE
Early markers of subclinical pulmonary vascular radiation toxicity in breast cancer
FL DEPT OF HLTH BANKHEAD-COLEY CANCER RE ·
Mar 2016 – Aug 2019
PHARMACOLOGIC INHIBITION OF ACETYLTRANSFERASE CBP/P300 AS ANEW THERAPEUTIC APPROACH FOR BREAST CANCER
FL DEPT OF HLTH BIOMED RES PGM/J&E KING · Project Manager
Dec 2015 ACTIVE
Miscellaneous Donors
MISCELLANEOUS DONORS · Principal Investigator
Jun 2015 – Sep 2019
Novel agents downregulate Her2, EGFR
US ARMY MED RES ACQUISITION · Project Manager
Apr 2015 ACTIVE
Clinical and Translational Science Institute (CTSI)
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
Feb 2015 ACTIVE
UF Health Cancer Center Pilot Project Grants funded through the Florida Consortium of National Cancer Institute Centers Program
UF HEALTH SHANDS HOSPITAL · Project Manager
Feb 2015 – Jan 2017
Patient derived xenograft model studies of metastases in
UF FOU · Principal Investigator
Jul 2014 – Dec 2018
The Role of the Intestinal Microbiota in the Development
FL BREAST CANCER FOU · Project Manager
Jun 2014 – May 2016
Endobronchial Photoacoustic Microscopy for Staging of Lu
US ARMY MED RES ACQUISITION · Project Manager
Apr 2013 – Mar 2019
Carbonic anhydrase and pH control in breast cancer cells
NATL INST OF HLTH NCI · Project Manager
Mar 2010 – Feb 2016
Transplacental stem cell transplantation and evaluation
NATL INST OF HLTH NIDDK · Principal Investigator
Jul 2007 ACTIVE
Breast Cancer Research
UF FOU · Project Manager

Education

Fellowship – Oncology
2008 · Barnes-Jewish Hospital
Residency – Internal Medicine
2004 · Barnes – Jewish Hospital
Medical Degree
2002 · University of Oklahoma
Internship – Obstetrics and Gynecology
2002 · Stanford Hospital

Contact Details

Phones:
Business:
(352) 273-8008
Emails: